• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

瘢痕疙瘩患者视网膜母细胞瘤蛋白结合锌指结构基因第8外显子A(8)和A(9)位点突变研究

Mutations in A(8) and A(9) loci of exon 8 of retinoblastoma protein-interacting zinc finger gene of keloid patients

摘要目的 研究瘢痕疙瘩患者视网膜母细胞瘤蛋白结合锌指结构基因(RIZ)第8外显子A(8)和A(9)位点突变情况. 方法 2003年1月-2007年12月,笔者单位收治符合入选标准的门诊及住院瘢痕疙瘩患者19例.采集患者瘢痕疙瘩组织3~5g、外周静脉血3 mL,分别提取基因组DNA并测定浓度,PCR法扩增获取RIZ第8外显子A(8)和A(9)位点片段,产物行琼脂糖凝胶电泳检测大小,柱层析法纯化后进行DNA测序,寻找A(8)和A(9)位点片段突变,并判定突变种类和类型,对比瘢痕疙瘩组织和外周静脉血的基因突变是否一致.对数据行McNemar检验. 结果 提取的瘢痕疙瘩组织和外周静脉血DNA质量浓度分别为0.54、0.37 μg/μ.L,均>0.10μg/μL;瘢痕疙瘩组织和外周静脉血RIZ第8外显子A(8)位点片段DNA的PCR产物大小分别为235、238 bp,A(9)位点分别为242、244 bp,与所设计DNA片段大小基本一致;瘢痕疙瘩组织和外周静脉血RIZ第8外显子A(8)位点片段DNA的PCR产物纯度分别为1.81、1.75,A(9)位点分别为1.82、1.78,均>1.50.18例患者瘢痕疙瘩组织RIZ第8外显子A(8)位点发生突变,共6种基因突变,包括4种点突变、2种移码突变;9例患者瘢痕疙瘩组织RIZ第8外显子A(9)位点发生突变,共9种基 因突变,包括7种点突变、2种移码突变.无一例患者外周静脉血RIZ第8外显子A(8)、A(9)位点发生突变.与外周静脉血比较,患者瘢痕疙瘩组织RIZ第8外显子A(8)和A(9)位点的突变均有统计学意义(x2=16.06、7.11,P<0.05).结论 患者瘢痕疙瘩RIZ第8外显子A(8)和A(9)位点发生点突变和移码突变,这可能与瘢痕疙瘩的发生有关.

更多

abstractsObjective To study the situation of the mutations in the A(8) and A(9) loci of exon 8 of retinoblastoma protein-interacting zinc finger gene (RIZ) of keloid patients.Methods From January 2003 to December 2007,19 outpatient and hospitalized keloid patients of our hospital were conforming to the inclusion criteria.Both 3-5 g keloid tissue and 3 ml peripheral venous blood were collected from each patient to extract their genomic DNA,and the concentration was determined.The A(8) and A(9) loci fragments of exon 8 of RIZ were amplified by polymerase chain reaction (PCR).The length of product was detected by agarose gel electrophoresis,anp DNA sequencing was performed after column chromatography.The mutations of A(8) and A(9) loci fragments were searched,and the types of mutations were determined.The consistency of genetic mutations of the keloid tissue and peripheral venous blood were compared.Data were processed with McNemar test.Results The DNA concentrations of the extracted keloid tissue and peripheral venous blood were 0.54 and 0.37 μg/tμL,respectively,which were above 0.10 μg/μL.The lengths of PCR products of A(8) locus fragment DNA of exon 8 of RIZ from keloid tissue and peripheral venous blood were 235 and 238 bp,respectively,and those of A(9) locus were 242 and 244 bp,respectively,which were basically the same as the designed DNA fragments.PCR products purity of A(8) locus fragment DNA of exon 8 of RIZ from keloid tissue and peripheral venous blood were 1.81 anp 1.75,respectively,and those of A(9)locus were 1.82 and 1.78,respectively,which were above 1.50.Mutations in the A(8) locus of exon 8 of RIZ were observed in keloid tissue of 18 patients,totally 6 gene mutations,including 4 point mutations and 2 frameshift mutations.Mutations in the A(9) locus of exon 8 of RIZ were observed in keloid tissue of 9 patients,totally 9 gene mutations,including 7 point mutations and 2 frameshift mutations.No patient had a m utation in the A(8) or A(9) locus of exon 8 of R IZ in peripheral venous blood.Compared with those of peripheral venous blood,the mutations in the A(8) and A(9) loci of exon 8 of RIZ in keloid tissue of patients were statistically significant (x2 =16.06,7.11,P < 0.05).Conclusions Point mutations and frameshift mutations occur in the A(8) and A(9) loci of exon 8 of RIZ in keloids of patients,which may be associated with the occurrence of keloids.

More
广告
栏目名称 短篇论著
DOI 10.3760/cma.j.issn.1009-2587.2018.09.015
发布时间 2018-11-02
基金项目
国家自然科学基金 广东省自然科学基金 广东省社会发展领域科技计划(83034)National Natural Science Foundation of China Natural Science Foundation of Guangdong Province of China Science and Technology Plan for Social Development of Guangdong Province of China
  • 浏览121
  • 下载69
中华烧伤杂志

中华烧伤杂志

2018年34卷9期

643-647页

MEDLINEISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷